U.S. Markets close in 3 hrs 33 mins

Merck KGaA Edges Full-Year Guidance Higher After Solid Q1 Earnings

Martin Baccardax

Merck KGaA posted slightly stronger-than-expected first quarter earnings Thursday and nudged its full-year profit guidance higher after a key drug approval in the United States.